Isoproterenol hydrochloride market concentration is high, Shandong Keyuan dominates

Isoproterenol hydrochloride is an organic substance with the chemical formula C11H18ClNO3. It is usually in the form of white or off-white crystalline powder. It is odorless and slightly bitter. Its chemical properties are relatively stable, but it is sensitive to air and light and is incompatible with strong oxidants. Easy to change color in alkaline solution.

As a raw material, isoproterenol hydrochloride can be used to treat bronchial asthma, cardiogenic or septic shock, and complete atrioventricular block after being made into finished medicines such as isoproterenol hydrochloride injection or aerosol. , cardiac arrest and other diseases. According to the “2022-2026 Isoproterenol Hydrochloride Industry In-depth Market Research and Investment Strategy Suggestions Report released by the Industrial Research Center , the global isoproterenol hydrochloride market size will be nearly 400 million yuan in 2021.

Industry analysts said that global manufacturers of isopropyl adrenaline hydrochloride are concentrated in countries and regions such as China and India. The pharmaceutical industries in China and India are developing rapidly. They actively take over the pharmaceutical industry in Europe and the United States by virtue of cheap labor and low land costs. They continue to improve the pharmaceutical industry chain and gradually become important pharmaceutical bases in the world. Among them, China has strong production capacity in isopropyl adrenaline hydrochloride API, but due to market capacity, its production scale is small. Representative companies include Shandong Keyuan Pharmaceutical Co., Ltd. and Shenzhen Woland Pharmaceutical Co., Ltd. , Jinan Renyuan Chemical Co., Ltd., etc.

Among them, the Indian company Cipla is the third largest pharmaceutical company in India. It is in a leading position in the Indian respiratory disease drug market. It mainly focuses on the Indian, South African and North American markets, and has built 46 production bases around the world. It is the world’s leading pharmaceutical company. An enterprise with relatively large output and relatively high brand awareness in the isoproterenol hydrochloride industry.

Shandong Keyuan Pharmaceutical Co., Ltd. is a high-tech pharmaceutical company jointly established by Linuo Group, the largest private enterprise in Shandong Province, and Shandong Pharmaceutical Industry Research Institute. It has established a complete quality management system in the production of isoproterenol hydrochloride. , has national GMP approval, and the isoproterenol hydrochloride produced can be directly used in the production of isoproterenol hydrochloride preparations.